https://www.diabesityrounds.com/a/diabetes-duration-and-insulin-use-predicted-remission-in-armms-t2dDiabesity Roundsen2026-10-21T20:32:29.269ZDiabetes duration and insulin use predicted remission in ARMMS-T2Dhttps://www.diabesityrounds.com/a/semaglutide-safety-by-egfr-in-flow-fewer-serious-adverse-events-than-placeboDiabesity Roundsen2026-10-21T20:17:35.649ZSemaglutide safety by eGFR in FLOW: fewer serious adverse events than placebohttps://www.diabesityrounds.com/a/cdsco-expert-committee-virchow-liraglutide-and-roche-petrelintide-trialsDiabesity Roundsen2026-10-21T20:01:55.786ZCDSCO expert committee: Virchow liraglutide and Roche petrelintide trials